Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Pediatr Dermatol ; 30(6): e246-7, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22299662

RESUMEN

A 7-year-old boy presented with an annular verrucous plaque on the chin of 5 weeks duration. The lesion occurred after a bicycle accident and was unresponsive to antibiotics. Fungal culture grew Sporothrix schenckii. Sporotrichosis should be considered and fungal culture obtained whenever a nodule or plaque fails to respond to initial treatment.


Asunto(s)
Ciclismo , Mentón/lesiones , Sporothrix/aislamiento & purificación , Esporotricosis/etiología , Heridas y Lesiones/microbiología , Accidentes , Niño , Mentón/microbiología , Humanos , Masculino , Esporotricosis/patología , Esporotricosis/terapia
2.
J Cutan Pathol ; 38(3): 275-9, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21121942

RESUMEN

Oral hairy leukoplakia (OHL) presents as a white, plaque-like lesion typically occurring on the lateral border of the tongue. This condition is caused by the Epstein-Barr virus, a human herpesvirus that often establishes lifelong, asymptomatic latent infection. OHL, initially described in immunocompromised men infected with the human immunodeficiency virus (HIV), has also been described in other severely immunocompromised patients. Only rarely has OHL been reported in less profoundly immunocompromised patients primarily in the setting of corticosteroid therapy. Here we report on two additional cases of OHL attributable to immunosuppressive medications.


Asunto(s)
Huésped Inmunocomprometido , Leucoplasia Vellosa/inmunología , Leucoplasia Vellosa/patología , Anciano , Antiinfecciosos/uso terapéutico , Antiinflamatorios/uso terapéutico , Antifúngicos/uso terapéutico , Artritis Reumatoide/complicaciones , Artritis Reumatoide/tratamiento farmacológico , Clobetasol/uso terapéutico , Dapsona/uso terapéutico , Fármacos Dermatológicos/uso terapéutico , Dexametasona/uso terapéutico , Diabetes Mellitus Tipo 2/complicaciones , Infecciones por Virus de Epstein-Barr/complicaciones , Femenino , Fluconazol/uso terapéutico , Humanos , Leucoplasia Vellosa/virología , Liquen Plano/complicaciones , Liquen Plano/tratamiento farmacológico , Metotrexato/farmacología , Nistatina/uso terapéutico , Prednisona/uso terapéutico , Óxido de Zinc/uso terapéutico
3.
Hum Pathol ; 43(3): 381-9, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21840568

RESUMEN

Neuropilin-2, a cell surface receptor involved in angiogenesis and axonal guidance, has recently been shown to be a critical mediator of tumor-associated lymphangiogenesis. Given that lymphangiogenesis is a major conduit of metastasis in melanomas and that blocking neuropilin-2 function in vivo is effective in inhibiting tumor cell metastasis, we sought to determine the clinical relevance of neuropilin-2 expression in cutaneous melanoma. Immunohistochemical analysis of neuropilin-2 expression was evaluated in nevomelanocytic proliferations that included a tissue microarray and histologic sections from samples of primary melanomas (n = 42; 40 for tissue microarray, 2 for histologic sections), metastatic melanomas (n = 30; 22 for tissue microarray, 8 for histologic sections), and nevi (n = 30; 5 for tissue microarray, 25 for histologic sections), as well as a panel of normal human tissues and select nonmelanocytic tumors. Staining for grading and intensity of neuropilin-2 expression was estimated semiquantitatively as follows for the former: less than 20%, 20% to 60%, and more than 60% of tissue present, and for the latter from 0 to 3, with 3 being the highest and 0 the lowest intensity. In nevomelanocytic proliferations, more than 20% staining for neuropilin-2 was noted in 36 (86%) of 42 cases of primary melanoma, in 27 (90%) of 30 cases of metastatic melanoma, and in 9 (30%) of 30 cases of nevi with differences achieving statistical significance between melanoma (primary and metastatic) and nevi (P < .0001). For staining intensity, an intensity of 2 or more was noted in 36 (86%) of 42 cases of primary melanoma, in 17 (57%) of 30 cases of metastatic melanoma and in 7 (30%) of 23 cases of nevi, with differences achieving statistical significance between melanoma (primary and metastatic) and nevi (P < .0001). In normal human tissue, consistently strong neuropilin-2 staining was noted in kidney (glomerular endothelial cells, collecting tubules, and collecting ducts), skin (epidermal keratinocytes), and testes (epithelium of the seminiferous tubules), whereas in tumoral tissue, consistently strong staining was noted only in renal cell carcinoma but not in any of the other tumors studied. More recently, using a heterotypic coculture methodology with melanoma and endothelial cells, we have demonstrated successful up-regulation of neuropilin-2 and confirmed the critical role of neuropilin-2 in melanoma-endothelial interactions. Because these coculture methods were developed to model melanoma metastasis, the significantly increased and enhanced expression of neuropilin-2 staining in primary and metastatic melanoma versus nevi in the current study suggests that it is also relevant in vivo.


Asunto(s)
Melanoma/secundario , Neuropilina-2/metabolismo , Neoplasias Cutáneas/patología , Biomarcadores de Tumor/metabolismo , Proliferación Celular , Técnicas de Cocultivo , Femenino , Humanos , Masculino , Melanocitos/metabolismo , Melanocitos/patología , Melanoma/metabolismo , Nevo/metabolismo , Nevo/patología , Neoplasias Cutáneas/metabolismo , Análisis de Matrices Tisulares
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA